Document is current
Any future updates will be listed below
-
Authors
Hoog, Meredith M. https://orcid.org/0009-0000-1954-847X
Vallarino, Carlos
Maldonado, Juan M.
Grabner, Michael
Teng, Chia-Chen
Terrell, Kendra
Richard, Emma L.
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 21 July 2025
Accepted: 28 August 2025
First Online: 9 October 2025
Declarations
:
: Meredith M. Hoog, Carlos Vallarino, Juan M. Maldonado, and Kendra Terrell are employees and stockholders of Eli Lilly and Company. Michael Grabner, Chia-Chen Teng, and Emma L. Richard are employees of Carelon Research, which received funding from Eli Lilly and Company for the conduct of this study as well as for manuscript writing. Michael Grabner, Chia-Chen Teng, and Emma L. Richardare stockholders of Elevance Health.
: Researchers accessed data in the format of a limited data set for which data use agreements were in place with the covered entities in compliance with the Health Insurance Portability and Accountability Act Privacy Rule. An Institutional Review Board did not review the study since only this limited data set was accessed. As this observational study used previously collected data and did not impose any intervention, the data were de-identified to protect participant privacy. Therefore, a formal Consent to Release Information form was not required. The study was conducted according to the ethical principles that originate in the Declaration of Helsinki and are consistent with Good Pharmacoepidemiology Practices and applicable laws and regulations in the US.
